CAR T therapy harnesses the power of your body’s own immune system to fight cancer. CAR T therapy is FDA approved for adults with aggressive B cell non-Hodgkin’s lymphoma who are not responding to chemotherapy and pediatric and young adult patients (up to 25 years of age) with acute lymphoblastic leukemia who are not responding to chemotherapy. Read more below on how the groundbreaking new treatment works.
